Corcept Therapeutics CFO Atabak Mokari disposes of 40,000 common shares for $3.52 million - CORT News | RalliesCorcept Therapeutics CFO Atabak Mokari disposes of 40,000 common shares for $3.52 million
C
CORT• CFO exercises options and sells shares
- Corcept Therapeutics CFO Atabak Mokari exercised stock options on July 15, 2026, acquiring 40,000 common shares at $19.26 to $23.06.
- He sold 40,000 common shares the same day at weighted-average prices of $86.78 to $89.43.
- His direct common stock holdings fell to 16,130 shares following the transactions.
